{"id":931,"date":"2020-05-14T22:27:43","date_gmt":"2020-05-14T22:27:43","guid":{"rendered":"http:\/\/balt.traffikstaging.com\/?post_type=news&#038;p=931"},"modified":"2022-04-06T17:23:11","modified_gmt":"2022-04-06T17:23:11","slug":"balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial","status":"publish","type":"news","link":"https:\/\/balt.traffikstaging.com\/fr\/news\/balt-receives-ide-approval-from-the-fda-to-begin-the-stem-trial\/","title":{"rendered":"Balt re\u00e7oit l'approbation IDE de la FDA pour commencer l'\u00e9tude STEM"},"content":{"rendered":"<p>Balt a annonc\u00e9 aujourd&#039;hui avoir re\u00e7u l&#039;approbation d&#039;exemption pour les dispositifs exp\u00e9rimentaux (IDE) de la Food and Drug Administration (FDA) des \u00c9tats-Unis pour commencer l&#039;essai Squid pour l&#039;embolisation de l&#039;art\u00e8re m\u00e9ning\u00e9e moyenne (STEM) pour le traitement de l&#039;h\u00e9matome sous-dural chronique.<\/p>\n<p><a class=\"btn-lined\" href=\"https:\/\/www.businesswire.com\/news\/home\/20200514005930\/en\/Balt-Receives-IDE-Approval-FDA-STEM-Trial\" target=\"_blank\" rel=\"noopener\">D\u00e9couvrez le communiqu\u00e9 de presse<\/a><\/p>","protected":false},"featured_media":0,"template":"","news_category":[],"class_list":["post-931","news","type-news","status-publish","hentry"],"acf":[],"ACF":false,"_links":{"self":[{"href":"https:\/\/balt.traffikstaging.com\/fr\/wp-json\/wp\/v2\/news\/931","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/balt.traffikstaging.com\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/balt.traffikstaging.com\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/balt.traffikstaging.com\/fr\/wp-json\/wp\/v2\/media?parent=931"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/balt.traffikstaging.com\/fr\/wp-json\/wp\/v2\/news_category?post=931"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}